"In accordance with the New York State Department of Health, we are requiring all hospital visitors to follow specific visitation guidelines for the safety of our patients, visitors and team members. Please visit our website to learn more. Huntington Hospital was recognized by U.S. News & World Report in nine specialties and is a 3-time recipient of the American Nurses Credentialing Center's Magnet Recognition Program."

During the past decade, Huntington Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Huntington Hospital" #1 sponsor was "Medtronic" with 4 trials, followed by "Northwell Health" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Duke University" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huntington Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Huntington Hospital" are "Heart Failure" (4 trials), "Atrial Fibrillation" (3 trials), "Arrhythmia" (1 trials), "Atrial Flutter" (1 trials) and "COVID" (1 trials). Many other conditions were trialed in "Huntington Hospital" in a lesser frequency.

Most popular intervention types in "Huntington Hospital" are "Other" (5 trials), "Device" (4 trials), "Drug" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "5 FUCMT (chemoradiation)" (1 trials), "Azimilide Dihydrochloride" (1 trials), "Bilateral Salpingectomy" (1 trials), "Bilateral Salpingectomy with Oophorectomy" (1 trials) and "Biospecimen Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Huntington Hospital" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Huntington Hospital". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Huntington Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Huntington Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".